Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

The University of Texas at Tyler was awarded a $219,000 grant to help fund a professor’s pulmonary fibrosis treatment project ...

Panelists discuss how managing patients with comorbidities requires careful evaluation to distinguish true Group 1 PAH features from underlying cardiac or pulmonary disease, with a more measured ...

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

COPD Updates: What's New in Pathophysiology and Management? Carlos Noujeim; Pierre Bou-Khalil Disclosures Expert Rev Resp Med. 2013;7 (4):429-437. The 'Frequent-exacerbation' Phenotype ...

Panelists discuss recent phase 3 trial results of a novel oral agent for idiopathic pulmonary fibrosis (IPF) and progressive ...

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine ...

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer ...

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...

Total pulmonary resistance, R L, was determined by addition of R p and R c After completion of the airway-resistance measurements, bronchography was performed with the use of finely particulate ...